Michael Oredsson: ‘What Makes Akkermansia Different from Other Probiotics’

Staff editor

11.10.2022

Michael Oredsson, CEO at The Akkermansia Company, discussed with the new postbiotic supplement containing pastorised Akkermansia muciniphila.

Michael Oredsson, CEO at The Akkermansia Company, discussed with Microbiomepost the new postbiotic supplement containing pastorised Akkermansia muciniphila.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Michael Oredsson: ‘What Makes Akkermansia Different from Other Probiotics’

Latest related content

MaaT Pharma secures €37.5M EIB financing to accelerate microbiome-driven breakthroughs in cancer care

Fiber may boost efficacy of fecal microbiota transplants for ulcerative colitis

How gut bacteria influence chemotherapy success and side effects

Previewing the PPPP congress: Prof. Francavilla on gut microbiota and gluten-related disorders in children

Fueling the future of microbiome science: inside the Global Grants for Gut Health

Mismatch in fecal transplants could disrupt gut balance and metabolism

Latest News